IOPAMIDOL — all Canadian products
12 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is IOPAMIDOL, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02229013 | ISOVUE 200 INJECTION | BRACCO IMAGING CANADA | Solution | Intravascular; Subarachnoidal | IOPAMIDOL 41 % | Marketed | |
| 02229021 | ISOVUE 300 INJECTION | BRACCO IMAGING CANADA | Liquid | Intravascular | IOPAMIDOL 61 % | Marketed | |
| 02229048 | ISOVUE 370 INJECTION | BRACCO IMAGING CANADA | Liquid | Intravascular | IOPAMIDOL 76 % | Marketed | |
| 02242122 | ISOVUE MULTIPACK-300 | BRACCO IMAGING CANADA | Liquid | Intravascular | IOPAMIDOL 61 % | Marketed | |
| 02242121 | ISOVUE MULTIPACK-370 | BRACCO IMAGING CANADA | Liquid | Intravascular | IOPAMIDOL 76 % | Marketed | |
| 02231260 | IOPAMIDOL INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | Intravascular | IOPAMIDOL 61 % | Cancelled Pre Market | |
| 02231261 | IOPAMIDOL INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | Intravascular | IOPAMIDOL 76 % | Cancelled Pre Market | |
| 01958011 | ISOVUE 128 INJ 26% | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | IOPAMIDOL 26 % | Cancelled Post Market | |
| 02229005 | ISOVUE 128 INJECTION | BRACCO IMAGING CANADA | Liquid | Intravenous | IOPAMIDOL 26 % | Cancelled Post Market | |
| 01958003 | ISOVUE 200 INJ 41% | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | IOPAMIDOL 41 % | Cancelled Post Market | |
| 01958976 | ISOVUE 300 INJ 61% | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | IOPAMIDOL 61 % | Cancelled Post Market | |
| 01958038 | ISOVUE 370 INJ 76% | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | IOPAMIDOL 76 % | Cancelled Post Market |
Browse other molecules: